Venture Capital

KingstronBio's successful implant of its advanced ProStyle M® heart valve kicks off a key study, signaling a new era for patients and China's medtech.

With a new CFO from Snap and a VP of Revenue from Shopify, Route is scaling up to dominate the lucrative post-purchase market for large retailers.

Former DARPA and NIWC Pacific leader Dr. Patrick Sims joins EverGlade, bringing insider expertise to the high-stakes world of federal R&D funding.

A new powerhouse is born in aviation as a consortium completes its acquisition of Air Lease, creating a titan poised to dominate a supply-constrained market.

Two-time Grammy winner Laufey receives ASCAP's Creative Voice Award, celebrating her genre-fusing sound and her mission to empower young musicians.

A new VC-backed program is giving elite female athletes the tailored health tools sports science has long ignored, aiming to optimize performance and longevity.

With $10M, Livid offers Vimeo users an escape from Bending Spoons' playbook of price hikes, backed by a free one-click video migration tool.

Following its Verinext acquisition, Arctiq is absorbing Atlassian powerhouse Forty8Fifty Labs, a key move in its strategy to dominate enterprise IT.

Backed by Intel Capital, Israeli startup Q-Factor claims an architectural leap in neutral atom tech to solve quantum computing's biggest hurdle: scale.

With a $137M war chest, Sidewinder Therapeutics is advancing a new class of ultra-precise cancer drugs aimed at tumors that have long evaded treatment.

The women-only agency expands into tennis, adding Grand Slam champ Sloane Stephens and signaling a new model for athlete representation and ownership.

A new report puts Switzerland and Singapore above the US and UK, arguing that institutional strength, not economic scale, is the key to investor safety.

Amid industry-wide financial strain, Kurin's simple device for preventing blood culture contamination delivers record growth by saving hospitals money and lives.

Memory giant SK hynix invests in Semidynamics, backing a radical new chip design that tackles AI's biggest bottleneck and aims to slash the cost of AI.

Hemispherian launches a landmark trial for GLIX1, a first-in-class therapy aiming to selectively destroy glioblastoma cells where others have failed.

Configit's upcoming summit highlights how CLM provides the data foundation for manufacturers to master mass customization and successfully deploy AI.

Baseload Capital's new kids' book uses a character named 'Fossi' to explain the complex shift from fossil fuels to renewables like geothermal energy.

With a massive $750M boost to its share buyback, Nutanix underscores its financial strength and bets on its future in hybrid multicloud and enterprise AI.

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.